Acquisition Opportunity Mathys was acquired by DJO in 2021, signaling potential alignment with DJO’s expanded distribution and portfolio strategy. Sales teams can explore cross-sell of complementary joint replacement solutions and leverage DJO’s channels for Mathys products in target markets.

Global Footprint Headquartered in Switzerland with development and production in Europe and subsidiaries in 10 countries, Mathys offers international sales potential. Focus on expanding distribution, training, and service support in new regions to drive adoption of hip, knee, shoulder implants and bone graft substitutes.

Medical Tech Stack Utilizes modern digital platforms (Power Apps, Power BI, Azure DevOps, SharePoint, Teams) for operations, data analytics, and collaboration. Opportunity to propose digital workflow optimizations, data integration with hospital systems, and enhanced post-market analytics to improve outcomes and efficiency.

Product Focus Specializes in joint replacement implants and synthetic bone graft substitutes. Upsell potential to hospitals and clinics through value-based offerings, surgeon training programs, and bundled solutions that address total joint care and rehabilitation pathways.

Growth Signals Recent news notes historical acquisition and a revenue scale in the lower mid-market bracket. Target mid-sized healthcare providers and distributors seeking proven orthopedic portfolios with established international support and potential for expansion into new geographies and product lines.